Summary of this blog
- Longevity market entry is a decision about which buyer to serve first and which claim you can prove to her. The category rewards the brand that narrows: one buyer, one claim with evidence behind it, one channel worked to depth before the next.
- The demand is real and sceptical at once. McKinsey’s 2025 Future of Wellness survey puts the global wellness market at $2 trillion, with 84% of US and 79% of UK consumers calling wellness a top or important priority and up to 60% saying healthy ageing is a top or very important priority. Those same buyers have watched claims fail before.
- Five moves. Pick one buyer: consumer, clinic, employer or payer. Choose the evidence position. Set the channel order. Prove before you scale. Measure the entry on one number.
- Health changes the claim. The Federal Trade Commission’s (FTC) health products guidance in the US, the Advertising Standards Authority’s (ASA) rules on health claims in the UK and the General Medical Council’s (GMC) standards for doctors decide what a longevity brand may say before any customer does.
- Judge the entry on one number: the repeat purchase, re-booking or renewal rate of the first cohort, before the budget to scale is released.
Longevity market entry is a decision about which buyer to serve first and which claim you can prove to her. The category has four buyers. A consumer buying a supplement, a test or a programme for herself. A clinic adding a longevity service line. An employer buying a benefit for its staff, and a payer buying a reduction in future claims. Each buys a different thing on different evidence, and a brand that enters for all four at once enters for none.
The demand is real and sceptical at once. McKinsey’s 2025 Future of Wellness survey, from more than 9,000 consumers across China, Germany, the UK and the US, puts the global wellness market at $2 trillion. The US market alone is more than $500 billion a year, growing 4 to 5% a year. In the same survey, 84% of US and 79% of UK consumers call wellness a top or important priority, and up to 60% say healthy ageing is a top or very important priority. Those buyers have also watched claims fail. A longevity market entry built on a promise rather than a proof is noticed, and then ignored.
This guide sets out five longevity market entry moves for the founder or marketing lead at a wellness brand, clinic group or health company entering the category. Our pillar on HealthTech go-to-market strategy covers the general plan. Our guide to marketing for longevity covers the channels once the entry is made, and our guide to longevity brand positioning covers the words.
Longevity market entry is a decision about which buyer to serve first and which claim you can prove to her. A brand that enters for everyone with a promise it cannot evidence is a brand the category does not remember.
The claim test before any plan
Write the one sentence the brand wants a customer to believe. Then ask two people to read it: a regulator’s lawyer and the most sceptical customer you can find. If either would ask for the evidence and the brand cannot produce it, the sentence is a wish. A longevity market entry plan starts from the strongest sentence that survives both readers.
1. Pick one buyer: consumer, clinic, employer or payer
The first move is the buyer, and the rule is one. A consumer buys a feeling and a result she can notice, pays monthly and leaves the month she stops noticing. A clinic buys a service line its clinicians will stand behind, with a protocol, a price per patient and a referral path. An employer buys a benefit its staff will use and its finance team can defend. A payer buys a measured reduction in future cost, on evidence that takes years. Longevity market entry for all four at once produces a website that speaks to nobody.
How to choose
Three questions. Which buyer already asks for what the brand does, in her own words, today. Who can the brand reach in the first year without a sales team or a clinical trial. Whose evidence bar can the brand clear with what it holds. For most wellness brands the answer is the consumer; for a clinic group it is its own patients; for a diagnostic or data company it is the clinic. Longevity market entry chooses from those three answers rather than from the largest market size.
A worked example
Take an illustrative case: a UK supplement brand with one formulation and a small clinical adviser group. The payer is out of reach for years, the employer wants a platform rather than a product, and the clinic wants a protocol the brand has not written. The consumer who already searches for the ingredient by name is the buyer, and the longevity market entry plan is built for her: one product, one claim, one channel. At Healthora, we have seen that longevity brands which pick one buyer for the first year tend to see a noticeable rise in qualified enquiries from that buyer, because every page finally answers her question.
2. Choose the evidence position
The second move is the claim. Longevity brands sit on a line from “supports healthy ageing” to “adds years of healthy life”, and the regulator and the sceptical buyer both read where the brand stands. The evidence position is the strongest claim the brand can support, in words the regulator accepts. In the US the FTC’s Health Products Compliance Guidance expects health claims to rest on competent and reliable scientific evidence. In the UK the Advertising Standards Authority’s guidance on food and health claims governs what a supplement may say. A clinic whose doctors offer interventions is held to the General Medical Council’s key points on marketing them. Longevity market entry chooses the position before the copy is written.
The three positions
Feel: the brand claims a change the customer notices, supported by customer-reported outcomes collected the same way every time. Measure: the brand claims a change in a biomarker, supported by a measured cohort. Treat: the brand claims a clinical outcome, supported by a trial and a regulatory status. Most longevity market entry decisions are made at feel or measure, and the mistake is to write copy at treat while holding evidence at feel. A brand that says less than it could proves more than its competitors, and the sceptical buyer notices.
The quick test
Take the homepage and underline every sentence that makes a claim. Beside each one write the evidence the brand holds and the regulator’s category it falls in. Any sentence with nothing beside it is rewritten to the position the evidence supports, or removed. Thirty minutes, once a quarter, is the longevity market entry claims audit. McKinsey’s 2024 consumer wellness research found more than 60% of consumers say longevity purchases are important and 70% plan to buy more. Those buyers compare the claims across brands.
3. Set the channel order
The third move is the order of channels, because a new entrant cannot fund all of them and the order decides whether the first customers trust the brand. Longevity market entry works best from the channel where the buyer already looks, adding the next only when the first produces repeat customers. For a consumer brand that is usually organic search on the ingredient or the outcome, then email, then a practitioner partnership, then community and referral, then paid. For a clinic it is its own patient base, then search, then local referral.
Why search comes first
A buyer who searches for the outcome or the ingredient has already decided to look. A page that answers her question with the evidence position behind it converts without an advertisement. Paid first spends the entry budget teaching the market the brand’s name before the brand has proved anything, and a longevity market entry budget is rarely large enough to teach and prove at once.
The partnership channel in health
Clinicians, trainers, pharmacists and practitioners are the channel the consumer trusts most and the channel the regulator watches most. A longevity market entry plan gives each partner the evidence position in writing, the claims they may repeat, and the claims they may not. In the US, under the FTC’s 2024 rule banning fake reviews and testimonials, a partner’s testimonial has to be a real one, and the brand carries the responsibility for it.
A specialist’s view on your entry
Want the longevity market entry claims audit run on your homepage?
Book a free consultation with Healthora. We’ll read your claims the way a regulator and a sceptical buyer would, tell you candidly which buyer your evidence can serve first, and share practical recommendations you can apply this quarter, whether you decide to work with us or not.
Book a Free Consultation4. Prove before you scale
The fourth move is the proof the brand earns before it releases the budget to scale. One cohort of first customers, measured on the outcome the evidence position claims, over the period it takes to notice: ninety days for a feel claim, six months for a measure claim. A longevity market entry that scales before the cohort reports is scaling a promise. The sceptical buyer is waiting for the review that says it did not work.
What counts as proof at each position
At feel, a repeat purchase rate and a customer-reported outcome collected the same way every time. For measure, the biomarker before and after in the first cohort, reported with its dropouts. Treat needs the trial and the regulator’s decision. The proof is published on an evidence page in the words the position allows, with the method beside the result, so the sceptical buyer can check it. Our case studies show what that evidence work looks like in the engagements we have run.
What we see when the proof exists
At Healthora, we have seen that longevity brands which publish a first-cohort outcome with its method tend to see more qualified enquiries from clinics and practitioners, because the evidence page gives a professional something she can defend. Brands that scale on testimonials alone tend to buy traffic that does not come back. The longevity market entry proof is the asset that outlasts the launch.
5. Measure the entry on one number
The fifth move is the number, and it is a repeat. Repeat purchase for a consumer brand, re-booking for a clinic, renewal for an employer, a continued contract for a payer. First-month revenue measures the launch; the repeat measures whether the claim held when the customer checked it against her own experience. A longevity market entry judged on the repeat rate of its first cohort knows within two quarters whether it has earned the right to scale.
The entry scorecard
Four rows: qualified enquiries or first purchases by channel; the repeat rate of each monthly cohort; the cost to acquire a customer who repeated; and the claims audit result. One page, monthly, read by the founder. The row that stalls says which move is wrong. Enquiries without repeats is an evidence problem; repeats without enquiries is a channel problem. That page is the longevity market entry scorecard.
When to release the scale budget
When two consecutive cohorts repeat at the rate the plan assumed, the claims audit is clean, and the cost of a repeating customer sits below the margin she brings. Then the next domino falls: the second channel, the second buyer, the second claim. Longevity market entry done this way is slower in the first quarter and faster in the fourth.
Longevity market entry in practice: the first two quarters
Longevity market entry takes two quarters to judge. The first month picks the buyer from the three questions and writes the evidence position, with the claims audit run on every page. Then months two and three build the first channel to depth: the search pages on the outcome and the ingredient, the evidence page with the method, the email sequence for the first cohort. The second quarter runs the first cohort, collects the outcome the same way every time, fills the scorecard monthly, and holds the scale budget until two cohorts repeat.
The change shows first in the enquiries. They arrive from the buyer the brand chose, asking the question the pages answer, and the sceptical ones arrive with the evidence page already read. Then the first cohort reports, the repeat rate says whether the claim held, and the scorecard says which move to fix. By the end of the second quarter the brand has either a repeat rate worth scaling or a lesson worth more than the budget it saved. That is the longevity market entry decision made on evidence rather than on hope.
The recap below lists the five moves in the order to make them.
- Pick one buyer: consumer, clinic, employer or payer. The one who already asks for what the brand does, can be reached in year one, and whose evidence bar the brand can clear.
- Choose the evidence position. Feel, measure or treat, the strongest claim the evidence supports in the regulator’s words. The longevity market entry claims audit on every page, quarterly.
- Set the channel order. The channel where the buyer already looks, worked to depth, then the next only when the first produces repeat customers. Partners briefed on what they may and may not say.
- Prove before you scale. One first cohort, measured on the claimed outcome over the period it takes to notice, published on an evidence page with its method.
- Measure the entry on one number. The repeat rate of each cohort, on a four-row scorecard, monthly. A longevity market entry scale budget is released when two cohorts repeat.
The five longevity market entry moves can be made by the founding team, by a specialist agency, or by the two together. Our services and case studies show what the entry work looks like in engagements we have run, and the moves above are where that work starts.
A specialist in health understands that the longevity buyer has heard the promise before. The consumer checks the claim against her own experience, the clinic checks it against the evidence, and the regulator checks it against the rules. Pick one buyer, choose the position the evidence supports, work one channel to depth, prove it on a cohort, and measure the repeat. Then the brand earns the right to scale.
Ready to enter the longevity category with a claim you can prove?
HEALTHORA SPECIALISES IN HEALTH
Book a free consultation with Healthora. We’ll identify which buyer fits your evidence, run the claims audit on your homepage with you, and share practical recommendations you can apply this quarter, whether you decide to work with us or not.
Book a Free ConsultationFrequently asked questions
What is longevity market entry?
The decision a wellness brand, clinic group or health company makes about which buyer to serve first in the longevity category, which claim it can prove to her, which channel to work first, what proof to earn before scaling, and the one number to judge the entry on. The category has four buyers, consumers, clinics, employers and payers, and each buys a different thing on different evidence.
Who buys longevity products and services?
Four buyers. Consumers buy a feeling and a result they can notice. Clinics buy a service line their clinicians will stand behind. Employers buy a benefit their staff will use, and payers buy a measured reduction in future cost. McKinsey’s 2025 Future of Wellness survey found up to 60% of consumers say healthy ageing is a top or very important priority, with 84% of US and 79% of UK consumers calling wellness a top or important priority.
How big is the longevity market?
McKinsey’s 2025 survey puts the global wellness market, of which longevity is a part, at $2 trillion, with the US market more than $500 billion a year and growing 4 to 5% a year. McKinsey’s 2024 research found more than 60% of consumers say longevity purchases are important and 70% plan to buy more. A longevity market entry plan treats those numbers as the size of the scepticism as much as the size of the demand.
What claims can a longevity brand make?
The strongest claim the evidence supports, in the words the regulator accepts. In the US the FTC’s Health Products Compliance Guidance expects health claims to rest on competent and reliable scientific evidence; in the UK the ASA’s guidance on food and health claims applies. Pick the position, feel, measure or treat, that the evidence supports, write the copy there, and run the longevity market entry claims audit quarterly.
Should a longevity brand sell to consumers or clinics first?
To the buyer who already asks for what the brand does, who can be reached in year one without a sales team or a trial, and whose evidence bar the brand can clear. For most wellness brands that is the consumer; for a diagnostic or data company it is the clinic; for a clinic group it is its own patients. A longevity market entry that picks both in year one builds a site that speaks to neither.
How do we know when to scale a longevity brand?
When two consecutive monthly cohorts repeat at the rate the plan assumed, the claims audit is clean, and the cost of acquiring a customer who repeated sits below the margin she brings. The repeat rate is the number, because first-month revenue measures the launch while the repeat measures whether the claim held. Then add the second channel, the second buyer or the second claim, one at a time.
What does Healthora charge for longevity market entry work?
Fees depend on scope, from a one-off claims audit with a buyer recommendation to an engagement that builds the evidence page, the first channel and the scorecard with your team. Fees are agreed for the engagement rather than billed by the hour. The consultation is free and produces a first view of which buyer your evidence can serve.
Keep reading
More on entering and growing in the longevity category: